跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TAZAC PULVULES nizatidine 300mg capsule - TGA Drug Approval Details
Approvals
/
TGA
/
TAZAC PULVULES nizatidine 300mg capsule
Approved
STANDARD
TAZAC PULVULES nizatidine 300mg capsule
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
c740a856910b04c6
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
c740a856910b04c6
Product Name
TAZAC PULVULES nizatidine 300mg capsule
Artg Id
49326
Artg Name
TAZAC PULVULES nizatidine 300mg capsule blister pack
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
1994-06-29
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/0a705bb80f97a076a3f4c79eee723877.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/352d145080ab671dd9f3457444c70461.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
c740a856910b04c6
Type
Standard
Back to TGA Approvals